|
Market Cap (24-Jun) $29,889,572 (1,428th) |
Close (30-Jun) $0.030 |
Volume (30-Jun) 960,646 |
Shortsold (12-Dec) 10,096 (0.00%) (692nd) |
|
52w High $0.000 |
52w Low $0.000 |
P/E - |
EPS 0 |
LBT released this announcement to the ASX on 29 October 2021, 10:22. The announcement is marked as price sensitive, and is 3 page(s) in length and 335.82kb in size.
You can view all announcements from LBT and see how they appear on a price chart on the announcements page.
At the date of this announcement, LBT was 0.003% short sold according to ASIC data. It was ranked the 692nd most shorted stock on the ASX. It remains ranked 692nd as of the latest reported data (12 December 2022).
| Other Recent Announcements from LBT | |
|---|---|
| APAS Presented at ASM Conference | 20 June 2023, 10:07 |
| APAS Compact Extension to Project Funding Timeframe | 20 June 2023, 10:06 |
| Notice under Section 708A - Cleansing Notice | 2 June 2023, 9:56 |
| US FDA 510(k) Clearance for MRSA Analysis Module | 29 October 2021, 10:22 |
| Quarterly Activities/Appendix 4C Cash Flow Report | 28 October 2021, 9:19 |
| Notice of Annual General Meeting/Proxy Form | 27 October 2021, 13:05 |
| Presentation at Australia Biotech Invest & Partnering 2021 | 26 October 2021, 10:06 |
You must be logged in to post a reply.
LBT Innovations 